The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre-surgical 68Ga-PSMA-11 PET for biochemical recurrence risk assessment: A surrogate of pelvic lymph node dissection? Follow-up analysis of a multicenter prospective phase 3 imaging trial.
 
Loic Djaileb
No Relationships to Disclose
 
Wesley Robert Armstrong
No Relationships to Disclose
 
Daniel Thompson
No Relationships to Disclose
 
Andrei Gafita
No Relationships to Disclose
 
Andrea Farolfi
No Relationships to Disclose
 
Tristan Grogan
No Relationships to Disclose
 
Matthew R. Cooperberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; ConcertAI; Dendreon; Exact Sciences; Merck; Pfizer; Veracyte; Verana Health
 
Peter Carroll
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; Nutcracker Therapeutics, Inc.
Honoraria - BIOPHARM; Exact Sciences
Consulting or Advisory Role - Alessa Therapeutics; Francis Medical; Insightec; Nutcracker Therapeutics, Inc.; Progenics
Research Funding - Intuitive Surgical (Inst)
 
Samuel L. Washington
Research Funding - ConcertAI
 
Robert Evan Reiter
No Relationships to Disclose
 
Matthias Eiber
No Relationships to Disclose
 
Ken Herrmann
Leadership - Pharma15; SOFIE; Theragnostics
Stock and Other Ownership Interests - Aktis Oncology; Pharma15; SOFIE; Theragnostics
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Bain Capital; Bayer; BTG; GE Healthcare; IPSEN; ITG (Inst); Novartis; ROTOP Pharmaka (Inst); Siemens Healthineers
 
Wolfgang P. Fendler
Honoraria - Parexel
Consulting or Advisory Role - Calyx; Janssen
Speakers' Bureau - Bayer; Janssen; Novartis; Telix Pharmaceuticals
Research Funding - SOFIE
 
Johannes Czernin
Leadership - SOFIE; Trethera
Stock and Other Ownership Interests - SOFIE; Trethera
Consulting or Advisory Role - Advanced Accelerator Applications; Aktis Oncology; Amgen; Jubilant Radiopharma; POINT Biopharma; RayzeBio
 
Thomas A. Hope
Stock and Other Ownership Interests - Curium Pharma; RayzeBio
Honoraria - GE Healthcare
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Curium Pharma; Ipsen; ITM Isotope Technologies Munich
Research Funding - Advanced Accelerator Applications (Inst); Clovis Oncology (Inst); GE Healthcare (Inst); Lantheus Medical Imaging (Inst); Philips Healthcare (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Jeremie Calais
Honoraria - Advanced Accelerator Applications; Curium Pharma; EXINI Diagnostics; Novartis; Progenics; Radiomedix
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Curium Pharma; GE Healthcare; Janssen; Lantheus Medical Imaging; Novartis; POINT Biopharma; Progenics; Radiomedix; Sanofi; SOFIE; Telix Pharmaceuticals
Speakers' Bureau - Lantheus Medical Imaging
Research Funding - Progenics